483 related articles for article (PubMed ID: 9706119)
1. Prevention of type 1 diabetes.
Rabinovitch A; Skyler JS
Med Clin North Am; 1998 Jul; 82(4):739-55. PubMed ID: 9706119
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to islet autoantigens in type 1 diabetes.
Bach JF; Chatenoud L
Annu Rev Immunol; 2001; 19():131-61. PubMed ID: 11244033
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
Nossal GJ; Herold KC; Goodnow CC
Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.
Rabinovitch A; Suarez-Pinzon WL
Biochem Pharmacol; 1998 Apr; 55(8):1139-49. PubMed ID: 9719467
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW; Jun HS
Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
[TBL] [Abstract][Full Text] [Related]
6. Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits.
Suarez-Pinzon WL; Rabinovitch A
Int J Exp Diabetes Res; 2001; 2(1):3-17. PubMed ID: 12369724
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
9. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
10. T-cell recognition of beta-cell autoantigens in insulin-dependent diabetes mellitus.
Kallan AA; de Vries RR; Roep BO
APMIS; 1996 Jan; 104(1):3-11. PubMed ID: 8645454
[TBL] [Abstract][Full Text] [Related]
11. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
12. Tolerogenic strategies to halt or prevent type 1 diabetes.
Cooke A; Phillips JM; Parish NM
Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
[TBL] [Abstract][Full Text] [Related]
13. Enhanced T cell responses contribute to the genetic predisposition of CD8-mediated spontaneous autoimmunity.
Garza KM; McKall-Faienza KJ; Otheki T; Zakarian A; Odermatt B; Ohashi PS
Eur J Immunol; 2002 Mar; 32(3):885-94. PubMed ID: 11870633
[TBL] [Abstract][Full Text] [Related]
14. Parameters influencing antigen-specific immunotherapy for type 1 diabetes.
Wang B; Tisch R
Immunol Res; 2008; 41(3):175-87. PubMed ID: 18543112
[TBL] [Abstract][Full Text] [Related]
15. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.
Akhtar I; Gold JP; Pan LY; Ferrara JL; Yang XD; Kim JI; Tan KN
J Exp Med; 1995 Jul; 182(1):87-97. PubMed ID: 7790825
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of autoimmune diabetes mellitus.
Rossini AA; Mordes JP; Greiner DL
Curr Opin Immunol; 1989-1990 Apr; 2(4):598-603. PubMed ID: 2700903
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.
Allen JS; Pang K; Skowera A; Ellis R; Rackham C; Lozanoska-Ochser B; Tree T; Leslie RD; Tremble JM; Dayan CM; Peakman M
Diabetes; 2009 Jan; 58(1):138-45. PubMed ID: 18835928
[TBL] [Abstract][Full Text] [Related]
18. T-cell responses to autoantigens in IDDM. The search for the Holy Grail.
Roep BO
Diabetes; 1996 Sep; 45(9):1147-56. PubMed ID: 8772714
[TBL] [Abstract][Full Text] [Related]
19. Molecular targeting of islet autoantigens.
Stadinski B; Kappler J; Eisenbarth GS
Immunity; 2010 Apr; 32(4):446-56. PubMed ID: 20412755
[TBL] [Abstract][Full Text] [Related]
20. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance.
Gregg RK; Bell JJ; Lee HH; Jain R; Schoenleber SJ; Divekar R; Zaghouani H
J Immunol; 2005 Jan; 174(2):662-70. PubMed ID: 15634884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
